These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17697011)

  • 1. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients.
    Yoneda M; Saito S; Ikeda T; Fujita K; Mawatari H; Kirikoshi H; Inamori M; Nozaki Y; Akiyama T; Takahashi H; Abe Y; Kubota K; Iwasaki T; Terauchi Y; Togo S; Nakajima A
    J Viral Hepat; 2007 Sep; 14(9):600-7. PubMed ID: 17697011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.
    Eguchi Y; Mizuta T; Ishibashi E; Kitajima Y; Oza N; Nakashita S; Hara M; Iwane S; Takahashi H; Akiyama T; Ario K; Kawaguchi Y; Yasutake T; Iwakiri R; Ozaki I; Hisatomi A; Eguchi T; Ono N; Fujimoto K
    Liver Int; 2009 Feb; 29(2):213-20. PubMed ID: 18710430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
    Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
    Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study.
    Tsochatzis E; Manolakopoulos S; Papatheodoridis GV; Hadziyannis E; Triantos C; Zisimopoulos K; Goulis I; Tzourmakliotis D; Akriviadis E; Manesis EK; Archimandritis AJ
    Aliment Pharmacol Ther; 2009 Nov; 30(9):947-54. PubMed ID: 19604179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adiponectin in chronic hepatitis C and B.
    Siagris D; Vafiadis G; Michalaki M; Lekkou A; Starakis I; Makri M; Margaritis V; Christofidou M; Tsamandas AC; Labropoulou-Karatza C
    J Viral Hepat; 2007 Aug; 14(8):577-83. PubMed ID: 17650292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in chronic hepatitis B virus infection.
    Kumar M; Choudhury A; Manglik N; Hissar S; Rastogi A; Sakhuja P; Sarin SK
    Am J Gastroenterol; 2009 Jan; 104(1):76-82. PubMed ID: 19098853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
    Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.
    Merchante N; Macías J; Ramayo E; Vergara S; García-García JA; Mira JA; Corzo JE; Gómez-Mateos JM; Lozano F; Pineda JA
    J Viral Hepat; 2006 Jul; 13(7):449-56. PubMed ID: 16792538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.
    Kawaguchi T; Ide T; Taniguchi E; Hirano E; Itou M; Sumie S; Nagao Y; Yanagimoto C; Hanada S; Koga H; Sata M
    Am J Gastroenterol; 2007 Mar; 102(3):570-6. PubMed ID: 17222321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
    Poustchi H; Negro F; Hui J; Cua IH; Brandt LR; Kench JG; George J
    J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study.
    Squillace N; Lapadula G; Torti C; Orlando G; Mandalia S; Nardini G; Beghetto B; Costarelli S; Guaraldi G
    HIV Med; 2008 Mar; 9(3):151-9. PubMed ID: 18218000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance.
    Otake S; Takeda H; Suzuki Y; Fukui T; Watanabe S; Ishihama K; Saito T; Togashi H; Nakamura T; Matsuzawa Y; Kawata S
    Clin Cancer Res; 2005 May; 11(10):3642-6. PubMed ID: 15897559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
    Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.